Home Credit Ratings and Research Fitch Research

Teva Pharmaceutical Industries Limited - Ratings Navigator

Published Apr 20, 2016

3 pages (2259 words) — Published Apr 20, 2016

Price US$ 500.00 | Buy this Report Now

About This Report

Brief Excerpt:

...Fitch Ratings does not foresee an upgrade in the near term, particularly given management's comments about remaining acquisitive even after closing its $40.5 billion acquisition of Allergan's generics unit....

Report Type:

Navigator

Company(ies)

Teva Pharmaceutical Industries Ltd. , Teva Pharmaceuticals USA Inc. , Teva Pharmaceutical Finance Company, LLC , Teva Pharmaceutical Finance II, LLC , Teva Pharmaceutical Finance Company B.V. , Teva Pharmaceutical Finance IV, LLC , Teva Pharmaceutical Finance II B.V. , Teva Pharmaceutical Finance IV B.V. , Teva Pharmaceutical Finance V B.V. , Teva Pharmaceutical Finance Netherlands II BV

Ticker(s)

TEVA

Issuer

Teva Pharmaceuticals USA, Inc.

Format:

PDF

Fitch Maintains Teva Pharmaceuticals' Ratings on Negative Watch – 2016/04/20 – US$ 149.00

Fitch Downgrades Teva Pharmaceuticals; Rates New Bonds 'BBB' – 2016/07/20 – US$ 149.00

Fitch Rates Teva Pharmaceutical's New EUR and CHF Bonds 'BBB' – 2016/07/22 – US$ 149.00

Fitch: Innovation, Regulation & Political Risks Key 2017 Themes for Global Pharma and Biotech – 2016/11/30 – US$ 149.00

Teva Pharmaceutical Industries Limited - Ratings Navigator – 2015/08/04 – US$ 500.00

Fitch Wire+: Generic Pharma Ratings Face Pressure From M&A Surge – 2015/08/13 – US$ 999.00

2017 Outlook: Global Pharma and Biotech – 2016/11/30 – US$ 750.00

Fitch Places Teva Pharmaceutical's Ratings on Watch Negative on Proposed Mylan Acquisition – 2015/04/22 – US$ 149.00

Fitch: Teva Remains on Watch Negative on Allergan Generics Acquisition – 2015/07/28 – US$ 149.00

Fitch: Generic Pharma Ratings Face Pressure From M&A Surge – 2015/08/13 – US$ 149.00

More from Fitch Research

Fitch Research—Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.

About the Author

Cite this Report


MLA:	Fitch Research. "Teva Pharmaceutical Industries Limited - Ratings Navigator" Apr 20, 2016. Alacra Store. May 14, 2025. <http://www.alacrastore.com/fitch-credit-research/Teva-Pharmaceutical-Industries-Limited-Ratings-Navigator-880554_report_frame>

APA:	Fitch Research. (). Teva Pharmaceutical Industries Limited - Ratings Navigator Apr 20, 2016. New York, NY: Alacra Store. Retrieved May 14, 2025 from <http://www.alacrastore.com/fitch-credit-research/Teva-Pharmaceutical-Industries-Limited-Ratings-Navigator-880554_report_frame>

US$ 500.00

$ £ €

Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

Example Report

Click to View Sample Report

More Research

Search all our Credit Research from one place.